Cardiac connexins, mutations and arrhythmias

Current Opinion in Cardiology

Volumn 27, Issue 3, 2012, Pages 236-241

  Delmar, Mario ^a   Makita, Naomasa ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

arrhythmogenic cardiomyopathy; arrhythmogenic right ventricular cardiomyopathy; connexin40 and connexin43; oculodentodigital dysplasia; progressive familial heart block; sudden infant death syndrome

Indexed keywords

CONNEXIN 40; CONNEXIN 43; GAP JUNCTION PROTEIN;

AMINO ACID SUBSTITUTION; CARDIOMYOPATHY; DESMOSOME; GENE MUTATION; GENETIC DISORDER; GERM LINE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART BLOCK; HUMAN; OCULODENTODIGITAL SYNDROME; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SUDDEN INFANT DEATH SYNDROME;

ACTION POTENTIALS; ARRHYTHMIAS, CARDIAC; ATRIAL FIBRILLATION; CARDIOMYOPATHIES; CONNEXIN 43; CONNEXINS; GENETIC PREDISPOSITION TO DISEASE; HEART BLOCK; HUMANS; MUTATION; MYOCARDIUM;

EID: 84859897711     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0b013e328352220e     Document Type: Review

References (48)

1. Weidmann S. The electrical constants of Purkinje fibres. J Physiol 1952; 118:348-360.
2. Revel JP, Karnovsky MJ. Hexagonal array of subunits in intercellular junctions of the mouse heart and liver. J Cell Biol 1967; 33:C7-C12.
3. Jansen JA, Noorman M, Musa H, et al. Reduced heterogeneous expression of Cx43 results in decreased Nav1.5 expression and reduced sodium current that accounts for arrhythmia vulnerability in conditional Cx43 knockout mice. Heart Rhythm (in press).
4. Danik SB, Rosner G, Lader J, et al. Electrical remodeling contributes to complex tachyarrhythmias in connexin43-deficient mouse hearts. FASEB J 2008; 22:1204-1212. (Pubitemid 351519974)
5. Paznekas WA, Boyadjiev SA, Shapiro RE, et al. Connexin 43 (GJA1) mutations cause the pleiotropic phenotype of oculodentodigital dysplasia. Am J Hum Genet 2003; 72:408-418. (Pubitemid 36194249)
6. Paznekas WA, Karczeski B, Vermeer S, et al. GJA1 mutations, variants, and connexin 43 dysfunction as it relates to the oculodentodigital dysplasia phenotype. Hum Mutat 2009; 30:724-733.
7. Shibayama J, Paznekas W, Seki A, et al. Functional characterization of connexin43 mutations found in patients with oculodentodigital dysplasia. Circ Res 2005; 96:e83-e91.
8. Seki A, Coombs W, Taffet SM, et al. Loss of electrical communication, but not plaque formation, after mutations in the cytoplasmic loop of connexin43. Heart Rhythm 2004; 1:227-233. (Pubitemid 38878243)
9. Gong XQ, Shao Q, Langlois S, et al. Differential potency of dominant negative connexin43 mutants in oculodentodigital dysplasia. J Biol Chem 2007; 282:19190-19202. (Pubitemid 47100175)
10. Gong XQ, Shao Q, Lounsbury CS, et al. Functional characterization of a GJA1 frameshift mutation causing oculodentodigital dysplasia and palmoplantar keratoderma. J Biol Chem 2006; 281:31801-31811. (Pubitemid 46041445)
11. Manias JL, Plante I, Gong XQ, et al. Fate of connexin43 in cardiac tissue harbouring a disease-linked connexin43 mutant. Cardiovasc Res 2008; 80:385-395.
12. Kalcheva N, Qu J, Sandeep N, et al. Gap junction remodeling and cardiac arrhythmogenesis in a murine model of oculodentodigital dysplasia. Proc Natl Acad Sci U S A 2007; 104:20512-20516.
13. Dobrowolski R, Sasse P, Schrickel JW, et al. The conditional connexin43- G138R mouse mutant represents a new model of hereditary oculodentodigital dysplasia in humans. Hum Mol Genet 2008; 17:539-554. (Pubitemid 351201767)
14. Van Norstrand DW, Asimaki A, Rubinos C, et al. Connexin 43 mutation causes heterogeneous gap junction loss and sudden infant death. Circulation (in press).
15. Wolf P, Abbott R, Kannel W. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22:983-988.
16. Fox CS, Parise H, D'Agostino RB Sr, et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA 2004; 291:2851-2855. (Pubitemid 38747806)
17. Yang Y, Xia M, Jin Q, et al. Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am J Hum Genet 2004; 75:899-905. (Pubitemid 39390498)
18. Xia M, Jin Q, Bendahhou S, et al. A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. Biochem Biophys Res Commun 2005; 332:1012-1019. (Pubitemid 40798187)
19. Olson TM, Alekseev AE, Liu XK, et al. Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. Hum Mol Genet 2006; 15:2185-2191. (Pubitemid 43985509)
20. Darbar D, Kannankeril PJ, Donahue BS, et al. Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation. Circulation 2008; 117:1927-1935. (Pubitemid 351543468)
21. Hodgson-Zingman DM, Karst ML, Zingman LV, et al. Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation. N Engl J Med 2008; 359:158-165. (Pubitemid 351962039)
22. Gollob MH, Jones DL, Krahn AD, et al. Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N Engl J Med 2006; 354:2677-2688.
23. Thibodeau IL, Xu J, Li Q, et al. Paradigm of genetic mosaicism and lone atrial fibrillation: physiological characterization of a connexin 43-deletion mutant identified from atrial tissue. Circulation 2010; 122:236-244.
24. Sato PY, Coombs W, Lin X, et al. Interactions between ankyrin-G, Plakophilin- 2, and Connexin43 at the cardiac intercalated disc. Circ Res 2011; 109:193-201.
25. Sato PY, Musa H, Coombs W, et al. Loss of plakophilin-2 expression leads to decreased sodium current and slower conduction velocity in cultured cardiac myocytes. Circ Res 2009; 105:523-526.
26. Lin X, Liu N, Lu J, et al. Subcellular heterogeneity of sodium current properties in adult cardiac ventricular myocytes. Heart Rhythm 2011; 8:1923-1930.
27. Tester DJ, Ackerman MJ. Sudden infant death syndrome: how significant are the cardiac channelopathies? Cardiovasc Res 2005; 67:388-396. (Pubitemid 41024866)
28. Schwartz PJ, Priori SG, Dumaine R, et al. A molecular link between the sudden infant death syndrome and the long-QT syndrome. N Engl J Med 2000; 343:262-267. (Pubitemid 30490394)
29. Ruan Y, Liu N, Priori SG. Sodium channel mutations and arrhythmias. Nat Rev Cardiol 2009; 6:337-348.
30. Firouzi M, Ramanna H, Kok B, et al. Association of human connexin40 gene polymorphisms with atrial vulnerability as a risk factor for idiopathic atrial fibrillation. Circ Res 2004; 95:e29-e33.
31. Lenegre J. Etiology and pathology of bilateral bundle branch block in relation to complete heart block. Prog Cardiovasc Dis 1964; 6:409-444.
32. Lev M, Kinare SG, Pick A. The pathogenesis of atrioventricular block in coronary disease. Circulation 1970; 42:409-425.
33. Probst V, Kyndt F, Potet F, et al. Haploinsufficiency in combination with aging causes SCN5A-linked hereditary Lenegre disease. J Am Coll Cardiol 2003; 41:643-652. (Pubitemid 36223331)
34. Watanabe H, Koopmann TT, Le Scouarnec S, et al. Sodium channel beta1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J Clin Invest 2008; 118:2260-2268. (Pubitemid 351872343)
35. Kruse M, Schulze-Bahr E, Corfield V, et al. Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I. J Clin Invest 2009; 119:2737-2744.
36. Makita N, Seki A, Sumitomo N, et al. A connexin 40 mutation associated with a malignant variant of progressive familial heart block type-1. Circ Arrhythm Electrophysiol (in press).
37. Basso C, Pilichou K, Carturan E, et al. Pathobiology of Arrhythmogenic Cardiomyopathy. In Corrado D, Basso C, Thiene G, guest editors. Arrhythmogenic Cardiomyopathy. Thakur RK, Natale A, editors. Cardiac Electrophysiology Clinics. Vol. 3. Philadelphia, PA: Elsevier; 2011. pp. 193-204.
38. Delmar M, McKenna WJ. The cardiac desmosome and arrhythmogenic cardiomyopathies: from gene to disease. Circ Res 2010; 107:700-714.
39. Kaplan SR, Gard JJ, Carvajal-Huerta L, et al. Structural and molecular pathology of the heart in Carvajal syndrome. Cardiovasc Pathol 2004; 13:26-32. (Pubitemid 38169463)
40. Kaplan SR, Gard JJ, Protonotarios N, et al. Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease). Heart Rhythm 2004; 1:3-11. (Pubitemid 38647241)
41. Asimaki A, Tandri H, Huang H, et al. A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. N Engl J Med 2009; 360:1075-1084.
42. Oxford EM, Musa H, Maass K, et al. Connexin43 remodeling caused by inhibition of plakophilin-2 expression in cardiac cells. Circ Res 2007; 101:703-711. (Pubitemid 47494101)
43. Morley GE, Vaidya D, Jalife J. Characterization of conduction in the ventricles of normal and heterozygous Cx43 knockout mice using optical mapping. J Cardiovasc Electrophysiol 2000; 11:375-377.
44. Thomas SP, Kucera JP, Bircher-Lehmann L, et al. Impulse propagation in synthetic strands of neonatal cardiac myocytes with genetically reduced levels of connexin43. Circ Res 2003; 92:1209-1216. (Pubitemid 36723648)
45. Danik SB, Liu F, Zhang J, et al. Modulation of cardiac gap junction expression and arrhythmic susceptibility. Circ Res 2004; 95:1035-1041. (Pubitemid 39532334)
46. Eckardt D, Theis M, Degen J, et al. Functional role of connexin43 gap junction channels in adult mouse heart assessed by inducible gene deletion. J Mol Cell Cardiol 2004; 36:101-110. (Pubitemid 38084795)
47. Delmar M. Connexin43 regulates sodium current; ankyrin-G modulates gap junctions: the intercalated disc exchanger. Cardiovasc Res 2012; 93:220-222.
48. Delmar M, Liang FX. Connexin 43, and the regulation of intercalated disc function. Heart Rhythm (in press).